Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACXIT Capital Partners was a Frankfurt-based independent corporate finance and financial advisory firm serving European middle-market clients and entrepreneurs. Its services included mergers and acquisitions advisory, capital markets advisory, restructuring, debt advisory, and strategic advisory across sectors including healthcare and pharmaceuticals, technology, and consumer industries. The firm was founded in 1999 and operated primarily from Frankfurt, Zurich, and Munich, with approximately 50 investment banking professionals at the time of its acquisition. ACXIT was acquired by Stifel Financial Corp. on July 1, 2022, and its team was integrated into Stifel's investment banking platform, particularly its DACH advisory operations. It was not itself a biotech, pharma, or healthcare operating company, but it did advise healthcare and pharmaceutical clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACXIT Capital Partners.